Regulation of apoptosis-associated genes in the regenerating liver

被引:35
作者
Fan, GS
Kren, BT
Steer, CJ
机构
[1] Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Cell Biol & Neuroanat, Minneapolis, MN 55455 USA
关键词
cell cycle; hepatocyte; proto-oncogene; retinoblastoma; signal transduction;
D O I
10.1055/s-2007-1007149
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The ability of the liver to regenerate remains a fascinating response to hepatic injury. Ever since the Greek myth of Prometheus, efforts have been made to unravel the mechanisms involved in liver regeneration. The cellular phenomenon represents an orchestrated response to external stimuli followed by sequential changes in gene expression, cytokine production, and morphologic structure. The most popular experimental model is based on the surgical removal of two-thirds of the liver: The remnant lobes respond to the loss of mass and function with expression of immediate- and delay-early genes which prime the cells for eventual progression through the cell cycle. The molecular events which trigger liver regeneration are now beginning to unfold. However, the control of liver regeneration and the events involved in regulating the three-dimensional growth of the organ remain poorly defined. It now appears that apoptosis probably plays a key role in fine tuning ire regenerative response. The list of apoptosis-related gene products seems to grow regularly and includes both pro- and antiapoptotic factors. It is noteworthy that many of these genes are critical mediators of both apoptosis and cell replication. The factors involved in predicting which pathway they chose provide the basis for uncovering the secrets of organ growth-be it by life or by death.
引用
收藏
页码:123 / 140
页数:18
相关论文
共 184 条
  • [61] FITZGERALD MJ, 1995, CELL GROWTH DIFFER, V6, P417
  • [62] HUMAN CLUSTERIN GENE-EXPRESSION IS CONFINED TO SURVIVING CELLS DURING IN-VITRO PROGRAMMED CELL-DEATH
    FRENCH, LE
    WOHLWEND, A
    SAPPINO, AP
    TSCHOPP, J
    SCHIFFERLI, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (02) : 877 - 884
  • [63] Abnormal centrosome amplification in the absence of p53
    Fukasawa, K
    Choi, T
    Kuriyama, R
    Rulong, S
    VandeVoude, GF
    [J]. SCIENCE, 1996, 271 (5256) : 1744 - 1747
  • [64] EXPRESSION AND STATE OF PHOSPHORYLATION OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT IN CYCLING AND NONCYCLING HUMAN HEMATOPOIETIC-CELLS
    FURUKAWA, Y
    DECAPRIO, JA
    FREEDMAN, A
    KANAKURA, Y
    NAKAMURA, M
    ERNST, TJ
    LIVINGSTON, DM
    GRIFFIN, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2770 - 2774
  • [65] C-fos is not essential for apoptosis
    Gajate, C
    Alonso, MT
    Schimmang, T
    Mollinedo, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 218 (01) : 267 - 272
  • [66] Cdc25 cell-cycle phosphatase as a target of c-myc
    Galaktionov, K
    Chen, XC
    Beach, D
    [J]. NATURE, 1996, 382 (6591) : 511 - 517
  • [67] Controlling cell death
    Golstein, P
    [J]. SCIENCE, 1997, 275 (5303) : 1081 - 1082
  • [68] Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo
    Grandori, C
    Mac, J
    Siebelt, F
    Ayer, DE
    Eisenman, RN
    [J]. EMBO JOURNAL, 1996, 15 (16) : 4344 - 4357
  • [69] PROMOTION AND INHIBITION OF ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS BY ONCOGENES AND RELATED SIGNALS
    GREEN, DR
    MAHBOUBI, A
    NISHIOKA, W
    OJA, S
    ECHEVERRI, F
    SHI, YF
    GLYNN, J
    YANG, YL
    ASHWELL, J
    BISSONNETTE, R
    [J]. IMMUNOLOGICAL REVIEWS, 1994, 142 : 321 - 342
  • [70] GRISHAM JW, 1962, CANCER RES, V22, P842